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ABSTRACT
Burkholderia cenocepacia is an opportunistic Gram-negative bacterium that causes
chronic respiratory infection in cystic fibrosis (CF) patients, leading to rapid decline of
lung function. CF patients harbour mutations in the gene encoding the cystic fibrosis
transmembrane conductance regulator (CFTR), a chloride (Cl-) transport channel. B.
cenocepacia survive in macrophages by delaying phagosome maturation and
exaggerate this strategy in CFTR-defective macrophages. Neutrophils of CF patients
display defective Cl- transport resulting in impaired chlorination of bacteria via
hypochlorous acid (HOCl), resulting in reduced bacterial clearance. I hypothesize that
macrophages with dysfunctional CFTR lack sufficient Cl- ion levels in their
phagosomes for the chlorination of engulfed B. cenocepacia and subsequent
clearance of the infection. B. cenocepacia were labelled with Cl--sensitive and -
insensitive fluorophores to measure the intraphagosomal Cl- ion concentration in
infected CFTR-normal and -defective murine macrophages and no significant difference
in the Cl- ion level was found at 1, 4 and 6 hrs post-exposure to Cl-- solution/Cl--free
gluconate solution . At 6 hrs post-exposure to Cl--solution/Cl--free gluconate solution,
there was also no significant difference in the survival rate of phagocytosed B.
cenocepacia in the 2 cell types exposed to Cl-. HOCl production was not detected in the
lysates of the 2 cell types suggesting that this bactericidal mechanism employed by
neutrophils is absent or undetectably low. Our results, showing no significant difference
in bacterial survival are consistent with the lack of HOCl production. A role for Cl- ions in
iv
connection with bacterial clearance from the macrophages examined remains to be
elucidated.
Key words: cystic fibrosis, cystic fibrosis transmembrane conductance regulator,
chloride sensor, chloride channel, macrophage, myeloperoxidase, Burkholderia
cenocepacia, intracellular pathogen
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1 Introduction
1.1 Cystic fibrosis transmembrane conductance regulator in epithelial cells
1.1.1 Structure, function, and regulation
Cystic fibrosis transmembrane conductance regulator (CFTR) is a voltage-independent,
protein kinase A (PKA)-regulated chloride (Cl-) channel belonging to the adenosine
triphosphate (ATP)-binding cassette (ABC) transporter family (67). The CFTR gene,
located on chromosome 7, encodes a 1480 amino acid protein that is present in the
plasma membrane of epithelial cells of the intestine, lung, kidney, pancreatic ducts,
salivary ducts, sweat ducts and vas deferens (30). The Cl--conductance pore of the
CFTR protein has 2 membrane-spanning domain (MSD)s, MSD1 and MSD2 each
consisting of 6 membrane-spanning alpha helixes, (Figure 1) (77). Cl- channel gating is
regulated by 2 intracellular nucleotide-binding domain (NBD)s, NBD1 and NBD2,
anchored to the carboxy termini of each of the MSDs (77). NBDs are ATP-hydrolysis
domains (77). PKA and protein kinase C (PKC) phosphorylate the CFTR regulatory
domain anchored to NBD1 and the amino terminus of MSD2, activating CFTR (77). The
regulatory domain of CFTR is a unique feature absent from other ABC transporters (30).
The membrane-spanning CFTR pore opens upon the binding of ATP to NBD1 and
NBD2, forming a NBD1-NBD2 complex enabling Cl- ion flow following the
phosphorylation of the regulatory domain (25). The hydrolysis of ATP interrupts the
interaction between NBD1 and NBD2 terminating Cl- ion flow (25). The C-terminus of
2CFTR contains PDZ-binding motifs that regulate CFTR activity and localization to the
plasma membrane (77). Transport proteins including the epithelial sodium channel
(ENaC), K+ channels, ATP-release mechanisms, anion exchangers, sodium-bicarbonate
transporters, and aquaporin water channels are also regulated by CFTR via the CFTR
carboxy terminus (30).
There are several molecular switches that regulate CFTR activity in the plasma
membrane. In their active forms, protein phophatase-2A (PP2A), adenosine
monophosphate-activated protein kinase (AMPK), syntaxin-1A (SYN1A), and
synaptosome-associated protein (SNAP23) are inhibiting proteins that diminish CFTR-
mediated Cl- secretion (30). PP2A dephosphorylates the CFTR C-terminus. AMPK
phosphorylates the C-terminus minimizing the depletion of ATP by CFTR during airway
inflammation. The 2 target-membrane soluble N-ethylmalemide-sensitive factor
attachment protein receptor (t-SNARE)s SNAP23 and SYN1A bind the N-terminus
sterically hindering PKA-mediated CFTR activation. Na+/H+ exchanger regulatory factor
isoform-1 (NHERF1), receptor for activated C-kinase-1 (RACK 1), protein kinase C
(PKC), protein kinase A (PKA) and ezrin enhance CFTR channel activity (30). NHERF1
is a PDZ binding protein that binds to the PDZ binding motif on the C-terminus of CFTR
stimulating CFTR Cl- permeability. RACK 1 tethers activated PKC to NHERF1. PKC and
PKA phosphorylate the regulatory domain of CFTR. PKC also phosphorylates the
molecular switch Ezrin. Ezrin binds to NHERF1 and increases NHERF1 binding affinity
to the PDZ-binding motif of the C-terminus of CFTR. Molecular switches are critical for
3the recruitment of kinases and phosphatases into signalling complexes that improve
specificity of signalling and amplify signals.
1.1.2 CFTR life cycle
A typical CFTR undergoes 4 stages of life cycle. The first stage consists of CFTR
biosynthesis, maturation and trafficking to the plasma membrane from the ER (3).
Endocytic retrieval to sorting endosomes from the plasma membrane is characteristic of
the second stage (3). In the third stage, endocytosed CFTR is recycled back to the cell
surface. The last stage involves targeting of endocytosed CFTR for degradation (3).
CFTR is translated and glycosylated with core sugars in the ER (101). Export of CFTR
from the ER to the Golgi is dependent on the consensus di-acidic ER exit motif
composed of 2 asparagine residues present in NBD1 (96). Glycosylated CFTR with the
proper ER exit motifs is trafficked to the Trans Golgi Network (TGN) for the modification
of core sugars into complex carbohydrates (96). Subsequently, CFTR is trafficked to the
apical plasma membrane. In Baby hamster kidney (BHK) and Chinese hamster ovary
(CHO), but not Henrietta Lacks cervical cancer (HeLa) and Human Embryonic Kidney
(293T) cells, CFTR was detected following a non-conventional route directly from the ER
to the late Golgi compartment skipping the cis Golgi compartment (101). It is
hypothesized that CFTR is subsequently recycled through a late Golgi endosomal
system to a mature glycosylated form (101).
4CFTR is constitutively internalized from the cell surface via clathrin mediated
endocytosis (9, 59). Traditionally two internalization motifs are involved in clathrin
mediated pathways are present on the C-terminus of CFTR: the tyrosine-based motif
(YDSI) and the di-leucine based motif (LL) (41). Also, the role of the CFTR N-terminus in
CFTR endocytosis remains to be determined (74). Endocytosed CFTR is targeted to
either the endosomal recycling compartment (ERC) or remains in sorting endosomes
that fuse with late endosomes and later lysosomes for degradation (8).
CFTR at the plasma membrane has been found to be recycled to the plasma membrane
rather than degraded upon internalization (73). The PDZ domain binding motif of CFTR
is an apical membrane, endocytic recycling motif that interacts with apical membrane
PDZ proteins that facilitate endocytic recycling (87). The PDZ domain binding motif
(DTRL) is on the C-terminus of CFTR (3). The mechanism governing the regulation of
endocytic trafficking by PDZ proteins is not clear, but it is believed that CFTR in vesicles
interacts via PDZ proteins with myosin motors that bind to F-actin and generate a
unidirectional vesicular movement along actin filaments (87). Rab GTPases facilitate
intracellular trafficking of CFTR (Figure 2) (3). Rab5 GTPase promotes CFTR trafficking
from the cell surface to early endosomes and subsequently to recycling endosomes
(26). Rab11 facilitates CFTR movement from recycling endosomes to the apical plasma
membrane, as well as to the TGN (26). Rab7 mediates CFTR trafficking from early
endosomes to late endosomes and from late endosomes to lysosomes (26). Rab9
rescues CFTR from late endosomes by trafficking CFTR to the TGN allowing CFTR to
5re-enter the secretory pathway that delivers CFTR to the plasma membrane (26). The
efficient reappearance of CFTR on the cell surface depends on the proper functioning of
modulating proteins.
1.1.3 Mutations leading to disease
Over 1,800 different mutations in the CFTR gene have been characterized (86). Within
the Caucasian population 1 in 20 individuals are carriers of mutations in the CFTR gene
(30). CFTR mutation carriers are at greater risk than the general population to develop
nasal polyposis, allergic bronchopulmonary aspergillosis, diffuse bronchiectasis,
azoospermia, congenital bilateral absence of the vas deferens, chronic pancreatitis and
chronic rhinosinusitis (17, 95). Mutations interfere with channel biogenesis, intracellular
trafficking, the number of channels embedded in the plasma membrane, channel
activity, and CFTR stability (67). The most common mutation consisting of a 3-
nucleotide base pair (bp) deletion results in the loss of a phenylalanine residue at amino
acid position 508 on the surface of nucleotide-binding domain1 of the CFTR protein (48,
56). It is proposed that the aromatic side-chain of F508 stabilizes the structural fold of
NBD1 and that the ΔF508-CFTR mutant may alter the di-acidic consensus endoplasmic 
reticulum (ER) exit motif-containing loop compromising its interaction with Sec24 subunit
of the COPII selection complex Sec23/Sec24 budding machinery (96). The resulting
CFTR phenotype is a misfolded, partially functional Cl- channel that fails to exit the ER
and instead is exported by ER chaperones to the proteosome for degradation resulting
in little or no CFTR at the cell surface (30).
6
7Figure 1. The schematic of the hypothesized structure of CFTR located at the
plasma membrane (77). CFTR is composed of 2 helical membrane spanning domains
(MSD1 and MSD2), as well as 2 nucleotide binding domains (NBD1 and NBD2) that
function as ATP hydrolysis domains regulating Cl- ion flow depending on the
phosphorylation state of the regulatory domain. The carboxy terminal (TRL) of CFTR
interacts with the cytoskeleton, ion channels and proteins (77).
8
9Figure 2. A model of CFTR endocytosis and recycling facilitated by distinct
cellular proteins (3). CFTR is endocytosed in a clathrin dependent process. The AP-2
adaptor complex modulates the interaction between the CFTR C-terminus and clathrin.
Rab GTPases influence CFTR trafficking. Rab5 mediates CFTR endocytosis, Rab4
promotes recycling of CFTR from sorting endosomes to the plasma membrane, Rab7
directs CFTR to the late endosome and subsequently to the lysosome for degradation,
Rab9 rescues CFTR from late endosomes to the TGN and Rab11 mediates CFTR from
recycling endosomes to the plasma membrane (3).
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Mutations in the CFTR gene leading to disruption in CFTR function occur via five distinct
mechanisms. Class I mutations are identified by premature transcript termination
resulting in an unstable truncated CFTR transcript or lack of CFTR expression (33).
Class II mutations are characterized by single nucleotide changes causing an amino
acid change in the CFTR protein resulting in a misfolded CFTR protein that is retained in
the ER and targeted to the proteosome for degradation (15). Class III mutations located
in the NBDs are responsible for irregular ATP-mediated channel activation leading to
diminished Cl- secretion by CFTR (4). Class IV mutations located in the MSDs lead to
defective channel gating resulting in poor Cl- conductivity across membranes (83). Class
V mutations are characterized by alternative splicing reducing the available amount of
functional protein to be exported to the plasma membrane (38).
1.1.4 Cystic fibrosis
Cystic fibrosis (CF) is a recessive autosomal genetic disease (75). CF is a rare disease;
however it is one of the most common lethal hereditary diseases in the Caucasian
population (75). 89.5% of individuals with CF carry at least one ΔF508-CFTR allele and 
51.3% of patients carry 2 copies of the ΔF508-CFTR allele (86). CF is responsible for 
multiorgan dysfunction. Airway disease, exocrine pancreatic insufficiency, an increase in
sweat NaCl concentration and male infertility are characteristic signs of CF (30).
Hindered expression of functional CFTR protein at the apical plasma membrane of
epithelial cells causes CF (75). Reduction of functional CFTR in the plasma membrane
by more than 90% leads to a deficiency in Cl- secretion and hyperabsorption of sodium
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diminishing the capacity of cilia to clear the airways of bacteria (30). In turn, the CF lung
is susceptible to chronic bacterial infections resulting in an aggressive inflammatory
response overproducing reactive oxygen species (ROS) and cytokines leading to lung
tissue damage and subsequent diminished respiratory function (30). Pulmonary
infections account for 85% of mortality cases associated with CF (2). Pulmonary
infections are often caused by opportunistic pathogens.
1.2 Burkholderia cenocepacia
1.2.1 Burkholderia cepacia complex
The Burkholderia cepacia complex (Bcc) is a group of 17 closely related Gram-negative
species or genomovars that are motile, aerobic, non-spore-forming, bacilli (28, 92).
Walter Hagemeyer Burkholder originally identified Bcc bacteria in the 1950s as the
causative agent of sour skin disease in onions, which manifests as soft rot in onion
tissue (13). Bcc species are organized into five genomovars representing groups of
phenotypically similar isolates that differ genetically (91). Bcc bacteria have large
genomes ranging from 5 to 9 Mb composed of multiple chromosomes possessing
several insertion sequences, which promote gene rearrangements increasing the
expression of neighbouring genes (55, 71). The genetic diversity and resulting metabolic
diversity enables Bcc species to metabolize a wide variety of carbon sources and adapt
to different environmental conditions including nutrient limitation, antibiotics,
antimicrobial peptides, and toxic compounds (94). Bcc bacteria are ubiquitous in nature
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residing in soil, water, animals, eukaryotic cells and the rhizosphere of plants (16, 18).
Bcc species are also opportunistic pathogens in immunocompromised and CF patients
(27, 43).Although Bcc species cause disease in onions and immunocompromised
patients, Bcc species predominantly participate in ecologically beneficial processes (61).
Bcc bacteria can degrade components of crude oil, herbicides, and components of
gasoline additives (24, 49, 64). Bcc bacteria are symbiotic nitrogen fixers in plant roots
(29). Bcc species also produce metabolites, which prevent fungi-mediated damping off
disease of crop seedlings including corn, cucumber, soybean, and sunflower (37, 57).
The potential in Bcc application in agriculture and industry as biological control agents,
substitutes for fertilizers, and bioremediation is offset by the risk of infecting vulnerable
individuals in the population.
1.2.2 B. cenocepacia
B. cenocepacia are opportunistic bacteria belonging to the Bcc. B. cenocepacia mostly
grow extracellularly, but are capable of intracellular survival in human alveolar epithelial
cells, dendritic cells, macrophages and neutrophils. B. cenocepacia are also capable of
growth in amoeba (93). B. cenocepacia belong to genomovar III of the Bcc (90). The
genome of B. cenocepacia consists of three chromosomes and one plasmid that
accounts for over 8 Mb with a GC content of 66.9% in total (39). Chromosome 1
encodes the majority of genes involved in housekeeping functions including central
metabolism and cell division. Protective responses, horizontal gene transfer and other
functions not essential for bacterial cell maintenance are encoded on the chromosomes
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2 and 3. Genomic islands harbouring mobile elements including transposons and
plasmids are present on each of the three chromosomes representing approximately
10% of the genome. Several insertion sequences are also dispersed throughout the
genome (39). Virulence factors encoded by the large genome are engaged in the
pathogenesis of human disease. Several encoded secretion systems have been
disrupted to identify the contribution of their secreted effector molecules to the disruption
of host cell processes leading to disease. B. cenocepacia express one type three
secretory system (TIIISS), which has been shown to be important for pathogenesis in a
murine model of B. cenocepacia lung infection (89). However, TIIISS is not important for
B. cenocepacia persistence within murine macrophages (52, 89). B. cenocepacia also
have 2 type four secretion system (TIVSS)s required for survival in epithelial cells and
macrophages (78). The type six secretion system (TVISS) deregulates Rho family
GTPases, which disrupts the actin cytoskeleton and delays the assembly of
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activation in
macrophages (5, 76).
1.2.3 Bcc and disease
Bcc bacteria are opportunistic pathogens in immunocompromised patients with chronic
granulomatous disease (CGD) and CF. Bcc infections are difficult to eradicate due to
their inherent resistance to antibiotics (1). Unlike other opportunistic pathogens, Bcc
bacteria are not part of the human commensal flora. Consequently, sources of Bcc
infections are of nosocomial or environmental origin (60). The occurrence of Bcc
14
infections has increased over the past 2 decades due to: increasing numbers of aging
immunocompromised patients; social and behavioural changes leading to close contact
between patients; and increase in resistance to antibiotics (61).
CF is characterized by impaired immunity and defective mucociliary clearance.
Pseudomonas aeruginosa is the most common CF pathogen followed by Bcc species B.
multivorans and B. cenocepacia (60). Infections caused by Bcc species lead to a more
rapid and serious deterioration in health and higher risk of mortality than P. aeruginosa
associated infections (19). CF patients infected with Bcc bacteria are at risk of
developing cepacia syndrome, which is exhibited by rapidly progressive necrotizing
pneumonia, septicaemia and early death (43). Among CF pathogens cepacia syndrome
is unique to Bcc isolates (60). Bcc bacteria, especially B. cenocepacia, B. multivorans,
and B. dolosa are transmissible among CF patients via aerosol droplets and direct
physical contact with infected patients (85). Nearly all Bcc genomovars have been
isolated from CF patients indicating that Bcc infections in CF patients are not species
specific (85). Clonal isolates have been recovered from patients exhibiting or not
exhibiting cepacia syndrome suggesting that in addition to bacterial factors host factors
also play a role in determining prognosis. The B. cenocepacia ET-12 lineage is
responsible for the largest CF epidemic in Canada, USA, and other parts of the world
(46, 61).
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CGD is a rare genetic disorder of polymorphonuclear leukocytes, characterized by
mutations in genes encoding the structural units of the NADPH oxidase, and interfering
with the proper assembly of NADPH oxidase on the phagosomal membrane, in turn
compromising production of superoxide (O2.-) necessary for the clearance of
phagocytosed microorganisms via oxidative killing (81). Following pneumonia with
dissemination caused by Aspergillus spp, sepsis and pneumonia caused by Bcc
infections are the second most common cause of mortality in CGD patients (98).
1.2.4 B. cenocepacia’s life cycle in murine bone-derived macrophages
B. cenocepacia taken up by macrophages reside in vacuoles termed B. cepacia
complex containing vacuoles (BcCV) that exhibit a delayed fusion with lysosomes
(Figure 3). The transient recruitment of early endosome autoantigen 1 (EEA1) to the
BcCV membrane shortly following phagocytosis indicates that BcCVs interact with early
endosomes and that the early events of vacuole maturation are not altered (52). 30 mins
post internalization BcCVs containing nonviable B. cenocepacia are surrounded by
lysosomal-associated membrane protein 1 (LAMP-1) in a punctate pattern on the
periphery of the BcCV, suggesting that BcCVs are interacting with late endosomes
and/or lysosomes. However, BcCVs containing viable B. cenocepacia accumulate
LAMP-1 6 hrs after internalization, suggesting a delay in the interaction of BcCVs with
late endosomes and/or lysosomes and in turn a delay in the progression of the maturing
BcCV towards a destructive compartment (52). Pulse-chase experiments with
tetramethylrhodamine-labelled dextran (TMR-dextran) for labelling lysosomes in
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macrophages show a 6 hrs delay in the colocalization of BcCVs containing viable B.
cenocepacia with lysosomes confirming the former (52). During this time BcCVs
containing viable B. cenocepacia maintain a luminal pH of 6.4, while vacuoles containing
heat-inactivated bacteria rapidly reach a pH of 4.8 (79). The 6 hr maturation delay is
also associated with a delay in NADPH oxidase assembly in the BcCV membrane.
Viable B. cenocepacia also inactivate the GTPase Rab7, which directs fusion of
vacuoles with lysosomes (2). These data suggest that B. cenocepacia evade
phagosomal maturation. Despite the delay in the maturing phagosome, viable BcCVs
eventually fuse with lysosomes (2).
1.2.5 B. cenocepacia’s life cycle in CFTR-defective murine bone-derived
macrophages
The CFTR-defective macrophages were obtained from mice generated from embryonic
stem cells in which the cftr gene was disrupted by gene targeting (50). Disruption of the
cftr gene in CFTR-defective macrophages was confirmed via genomic DNA PCR prior to
measuring and analyzing the intraphagosomal Cl- concentrations in murine bone-
derived CFTR-normal and CFTR-defective macrophages. The degree of similarity in
exons 10, 11 and 12 of the murine CFTR homologue to the human CFTR protein was
found to be 98, 91 and 92%, respectively (88). NBD1 that contains the most prevalent
CF mutation ΔF508 and several other mutations is encoded by nucleotide sequences in 
exons 9-12 of the human cftr gene and the equivalent mouse amino acid sequence
spans residues 433-586 (88). The disrupted cftr gene in the CFTR-defective
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macrophages contains an in frame stop codon at amino acid position 489 in the coding
sequence of exon 10 giving rise to a truncated gene product similar to that seen in
severe human CF mutations (50). A 400-bp fragment of murine exon 10 was amplified in
genomic DNA preparations from CFTR-normal macrophages (Figure 9).
The delay in the progress of phagosome maturation is further exaggerated in CFTR-
defective macrophages infected with B. cenocepacia. CFTR-defective macrophages
infected with B. cenocepacia also exhibit a more pronounced production of IL-1, which
promotes inflammatory responses and leukocyte infiltration (2). The increased IL-1β 
production could result from either increased bacterial burden in CFTR-defective
macrophages or the inherently defective autophagy activity (see section 1.2.6) (2).
1.2.6 B. cenocepacia’s effect on autophagy in CFTR-defective murine bone-
derived macrophages
Autophagy is a process responsible for maintaining host cell homeostasis by lysosomal
degradation of cytoplasmic content and non-functional organelles for the generation of
nutrients during stress (2). Autophagy is essential for clearing protein aggregates
consisting of misfolded polyubiquitinated proteins and organelles via lysosome
degradation (58). The accumulation of misfolded proteins is characteristic of many
human diseases including CF (58). Defective-CFTR has been shown to inhibit the
clearance of aggresomes via autophagy in mouse and human CF airway epithelial cells
(58).
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Figure 3. B. cenocepacia subverting phagosomal maturation (modified figure from
Dr. Julie Lamothe). BcCV trafficking and interaction with early endosomes upon
internalization occurs without deviation from the classical phagosomal pathway. A delay
of approximately 6 hrs occurs in the acidification of the BcCV and in the accumulation of
late endosome markers on the BcCV membrane suggesting that the BcCV is
manipulating traditional trafficking between early and late endosomes (52).
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It has been demonstrated that B. cenocepacia downregulate autophagy genes in CFTR-
normal and CFTR-defective macrophages (2). Diverting traffic from the normal
phagosomal pathway towards the autophagic pathway is a strategy employed by
intracellular pathogens attempting to evade the host immune response while developing
their intracellular niches to establish persistent infection (14). In CFTR-normal
macrophages BcCVs eventually reside in autophagosomes that fuse with lysosomes (2).
However, in CFTR-defective macrophages B. cenocepacia-mediated downregulation of
autophagy genes and inactivation of Rab7 results in a lack of BcCV associated
autophagosome characteristics and inhibited lysosomal fusion (2). Rapamycin an
autophagy stimulating pharmacological agent, has been shown to restore complete
autophagy and enhance B. cenocepacia clearance by normal- and CF-mouse bone-
derived macrophages, as well as diminish the bacterial burden along with the
accompanying inflammation in the lungs of CF mice (2). Defective autophagy may play
a fundamental role in CF pathogenesis.
1.3 Phagocytosis and the endosomal pathway
1.3.1 The classical endosomal pathway
Invading microorganisms are engulfed into plasma membrane-derived vacuoles by
professional phagocytes. The clustering of cell receptors interacting with ligands initiates
phagocytosis. The vacuolar lumen of the newly formed phagosome is similar to the
extracellular milieu and lacks the capacity to destroy the invading microorganism (80).
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The phagosome acquires microbicidal properties through sequential membrane fusion
and fission events with sorting endosomes, late endosomes, and lysosomes in a
maturation process (Figure 4) (80). The acquisition of sorting endosome characteristics,
including a mildly acidic environment (pH 6.1-6.5) with poor hydrolytic activity and
effector molecules Rab5, EEA1, Syntaxin-13 and PI(3)P by the nascent phagosome,
indicates fusion of these 2 compartments (80). EEA1 anchored by PI(3)P to the cytosolic
face of sorting endosomes is responsible for tethering sorting endosomes with endocytic
compartments (80). EEA1 also interacts with the SNARE molecule syntaxin-13 that
catalyzes membrane fusion and with NSF that disassembles the fusion complex (80).
Rab 5 regulates the targeting, tethering, and fusion of the sorting endosome with the
phagosome (11). This transient state progresses to a late endosomal-like state with the
loss of sorting endosome properties and the acquisition of late endosome characteristics
(80). This late phagosome becomes acidic and exhibits active proteases, the GTPase
Rab 7, the SNARE molecule syntaxin-7, mannose-6-phosphate receptors (M6PR),
lysobisphosphatidic acid (LBPA) and lysosomal-associated membrane proteins (LAMPs)
(80). Syntaxin-7 promotes late phagosome fusion with lysosomes. Rab 7 regulates the
interaction between late phagosomes and lysosomes(12). The interaction of Rab7
effector RILP with dynein-dynactin microtubule-associated motor complex facilitates the
migration of late phagosomes to lysosomes from the cell periphery to the perinuclear
region on microtubules (36). The resulting phagolysosome contains mature proteases
and acquires the vacuolar-type H+-ATPase (V-type ATPase) that pumps protons further
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Figure 4. Classical endosomal pathway resulting in phagosome maturation
(modified figure from Dr. Julie Lamothe). Bacteria taken up by macrophages reside in
bacteria containing vacuoles (BCV)s. BCVs interact with sorting and late endosomes
acquiring microbicidal properties. Upon fusion of BCVs with lysosomes bacteria are
degraded (80).
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acidifying the lumen (80). The microbicidal environment of the phagolysosome leads to
inactivation and degradation of invading microorganisms.
1.3.2 The role of CFTR in intraphagosomal acidification of professional
phagocytes
A common component of the phagosomal maturation pathway in professional
phagocytes is the acidification of the vacuole containing the internalized pathogen.
Vacuolar acidification promotes the activity of degradative enzymes including the
proteases such as elastases and cathepsins. Vesicular proton-ATPases hydrolyze ATP
to pump H+ into the phagosome. Channels including Cl- and K+ are thought to function
as charge shunts, which balance the inward movement of H+ cations by the inward
movement of Cl- anions or outward movement of K+ cations resulting in the generation
of an inward H+ gradient resulting in the accumulation of H+ in the vacuolar lumen
decreasing pH in the vacuole acidification of the vacuole (21, 35, 97). It was reported
that CFTR located on the phagosomal membrane plays a role as a charge shunt
secreting Cl- into the phagosomal lumen permitting the acidification of this vacuole in
murine and human alveolar macrophages (20). In contrast, multiple studies performing
ratiometric analysis with pH-sensitive and pH-insensitive fluorophores conjugated to
either dextran or zymosan particles during infection and in the absence of infection,
demonstrated that there is no variation in pH in the phagolysosomes between CFTR-
normal and CFTR-defective murine macrophages (31, 53).
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1.3.3 The role of CFTR in the chlorination of engulfed bacteria by professional
phagocytes
Pathogens taken up by phagocytes are killed by oxidative and non-oxidative ways in
phagosomes. NADPH oxidase is an enzyme complex playing a crucial role in the host
defence by professional phagocytes such as neutrophils and macrophages upon
assembly on phagosomal membranes. Critical to the antimicrobial activity of neutrophil
phagosomes is the generation of hypochlorous acid (HOCl) by a process relying on the
NADPH oxidase assembly and localized production of O2.- (69). O2.- is dismutated to
hydrogen peroxide (H2O2). The myeloperoxidase enzyme predominantly found in
neutrophils (MPO) binds H2O2 and oxidizes Cl- to generate the potent microbicidal agent
HOCl (Figure 5). Cl- is thought to be the major halide involved in this reaction (69).
Human CF neutrophils displayed a chlorination defect of internalized Pseudomonas
aeruginosa due to a lack of HOCl production (68).
1.3.4 Myeloperoxidase
The heme enzyme MPO is the dominant constituent of azurophilic granules found in the
cytoplasm of neutrophils (34). MPO performs as a heme peroxidase oxidizing
compounds. Unlike classical heme peroxidases, MPO oxidizes Cl- to a potent
bactericidal non-radical oxidant HOCl instead of oxidizing aromatic compounds to
radicals (Figure 5) (34). HOCl chlorinates multiple biological targets including bacterial
iron-sulfur proteins, membrane transport proteins, and ATP-generating systems (34).
The deoxyribonucleic acid (DNA) origin of replication is the most sensitive bacterial
target to HOCl (34). Chloramines generated upon reaction of HOCl with amines are also
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Figure 5. Oxidation of substrates by myeloperoxidase (34).
MPO engages in reactions with substrates via different redox intermediates. Ferric MPO
(MP3+) reacts with H2O2 forming the enzyme intermediate Compound I. Compound I
oxidizes Cl- to HOCl or thiocyanate to hypothiocyanous acid by a 2-electron transfer.
Compound I also oxidizes aromatic compounds (RH) including phenolic compounds and
ascorbate by 2 successive 1-electron transfers forming enzyme intermediate Compound
II. O2.- recycles Compound II back to ferric MPO (34). Formation of HOCl is inhibited by
Compound II or the O2.- adduct (MP2+O2). O2.- also converts MP3+ to MP2+O2 and
converts Compound I to Compound II inhibiting chlorination. However, O2.- also reacts
with Compound II converting this enzyme intermediate to MP3+ enhancing chlorination
(99).
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bactericidal (34). Iodide, bromide, thiocyanate and nitrate are also substrates of MPO
(34). Chlorination of tyrosine residues on the surface of Escherichia coli, Pseudomonas
aeruginosa and Staphylococcus aureus has been reported to occur within 5 min of
phagocytosis (66). HOCl-mediated chlorination affects both host phagosomal and
bacterial proteins with tyrosine residues, suggesting that HOCl is not selective.
1.4 Cl- detection methods
1.4.1 Survey of techniques
Over the last 4 decades, different methods have been developed and improved for
measuring concentrations of the most abundant physiological anion: Cl-. Studies of Cl-
transport across membranes have been complicated by technical limitations. Patch-
clamp techniques only measure conductive transport (51). Microelectrodes have limited
specificity, sensitivity and response rate (51). Recordings obtained without damaging
cells with microelectrodes are reliable only in large cells (63). Preparation of this method
is time-consuming, the method is invasive, and measurements are at risk of distortion
due to contamination of the electrode with anions from the intracellular milieu (51). 36Cl-
that is used in tracer studies displays low specificity activity, resulting in a tracer that is
composed of a low amount of radioactive atoms available for detection (51). Fluorescent
indicators are the contemporary method employed for non-invasively obtaining Cl-
measurements in biological systems.
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Exogenous Cl--sensitive fluorescent dyes including SPQ, MQAE and MQHA are based
on the heterocyclic aromatic compound quinolium. The relationship between Cl-
concentration and the fluorescence intensity of the quinolium compound is described by
the Stern-Volmer equation F0/F = 1 + Ksv[Cl-] where F0 is the emitted fluorescence in the
absence of halide, F is the emitted fluorescence in the presence of halide and Ksv is the
Stern-Volmer quenching constant (M-1). The Stern-Volmer equation defines collisional
quenching of the fluorochrome quinolium by the quencher Cl- (70). Cl--sensitive
fluorescent dyes display strong sensitivity and selectivity to Cl-, as well as rapid
responses to Cl- dynamics (10). An essential requirement of the quinolium-based Cl--
sensitive fluorescent dyes in measuring biological systems is their insensitivity to
changes in pH (10). A drawback of this technique is the susceptibility of these dyes to
bleaching due to requiring wavelengths between and in the ultraviolet range for
excitation (10). Cl--sensitive dyes also lack an isosbestic point, which corresponds to a
specific wavelength at which the emission spectra of a Cl--sensitive dye exposed to
different Cl- concentrations cross each other, precluding the use these dyes for
ratiometric measurements that depend on the isosbestic point as a Cl--independent
fluorescent signal for constructing the ratio of dye signal independent of Cl-
concentration to dye signal dependent of Cl- concentration (10). Dual wavelength
fluorescent indicators with Cl--sensitive and Cl--insensitive dyes linked by alkyl chain
spacers have been developed, but this conjugation reduced Cl- sensitivity (44).
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Endogenously expressed chromophores are genetically encoded Cl--sensitive proteins
that are targeted to specific organelles or expressed in specific cell types (10). The
ground-state binding by anions near the chromophore alters the ionization constant of
the chromophore and in turn changes the fluorescence emission (10). Several mutations
to the green fluorescent protein (GFP) have resulted in a yellow fluorescent protein
(YFP) derivative with improved brightness and Cl- sensitivity at the physiological
intracellular pH (7.2-7.4) (10). YFP-based Cl--sensors have 2 advantages over the
quinolium based Cl--sensors. First, the YFP- based Cl--sensors are excited in the visible
range resulting in a more stable fluorescence signal and less cell damage (10). Second,
these sensors can be used for in vivo systems by targeting specific cell types with cell-
specific promoters or specific cellular compartments and membrane domains via fusion
to short sequence tags or proteins unique to locations of interest (10). An inconvenience
concerning YFP-based Cl--sensors for monitoring Cl- in biological systems is that they
are sensitive to pH and require independent monitoring of pH (10). YFP derivatives also
lack an isosbestic point in normalized excitation spectra of different Cl- concentrations
precluding ratiometric measurements (10). An improved Cl- sensing probe called Cl--
sensor was developed consisting of Cyan Fluorescence Protein (CFP) connected with a
24 amino acid polypeptide linker to a variant of YFP, Topaz Fluorescence Protein (TFP)
that exhibited a clear isosbestic point. Additional mutations to TFP resulted in increased
sensitivity to Cl- within the physiological Cl- concentration range. The development of
fluorescent indicators has revolutionized intracellular Cl- monitoring without risking
damage to cells.
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1.5 Hypothesis and research objective
CFTR was shown to play no role in the acidification of the phagosomal lumen of
macrophages and instead was proposed to be involved in B. cenocepacia clearance
(53). Painter et al demonstrated using zymosan bound to a Cl--insensitive and Cl--
sensitive fluorophores that human neutrophils with dysfunctional CFTR have lower
phagosomal Cl- concentration than neutrophils with functional CFTR (70). Furthermore,
Painter et al also showed that dysfunctional CFTR in human neutrophils affects the
chlorination of the engulfed CF-pathogen Pseudomonas aeruginosa, suggesting that
CFTR is involved in bacterial clearance by neutrophils (69). Based on these
observations, I hypothesize that macrophages with dysfunctional CFTR lack sufficient
Cl- concentrations in their phagosomes that causes defects in the chlorination and
subsequent clearance of phagocytosed B. cenocepacia. The hypothesis is addressed by
2 specific objectives. The first specific objective focuses on developing a modified
version of the fluorophore-based probe used by Painter et al (70) to measure the
intraphagosomal Cl- concentration in CFTR-normal and CFTR-defective macrophages.
The second specific objective investigates enzymatic HOCl production by CFTR-normal
and CFTR-defective macrophages.
1.5.1 Specific objective 1: To develop a probe with Cl--sensitive and Cl--insensitive
fluorophores, and measure the intraphagosomal Cl- concentration in CFTR-normal
and CFTR-defective macrophages using the fluorophores.
The fluorophores will be linked to pathogenic B. cenocepacia instead of inert zymosan to
measure Cl- in phagosomes specifically containing B. cenocepacia. The purpose of
32
synthesizing a dual-label probe is to compare the fluorescent signal of the Cl--sensitive
fluorophore to a reference signal of the Cl--insensitive fluorophore allowing for the
determination of the Cl- concentration in phagosomes.
1.5.2 Specific objective 2: To assay for enzymatic HOCl production in uninfected
CFTR-normal and CFTR-defective macrophages.
It is unclear if the neutrophil MPO enzyme that is stored in azurophilic granules and
generates HOCl in phagocytes is present in macrophages because macrophages are
void of azurophilic granules. Few sources report MPO to be present in monocytes and
subpopulations of tissue macrophages (22). A colourimetric assay is used to specifically
detect MPO-like chlorination activity in CFTR-normal and CFTR-defective macrophage
cell lysates.
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2 Materials and Methods
2.1 Bacterial strains, media, growth conditions
B. cenocepacia MH1K, E. coli DH5alpha, and B. multivorans C5568 from our laboratory
stocks were grown in Luria-Bertani (LB) broth at 37°C with shaking or on LB plates with
1.6% Bacto agar. Optical density of overnight cultures was determined spectroscopically
at 600 nm.
2.2 Cell lines and cell culture conditions
The CFTR-defective bone marrow-derived macrophage cell line was produced from
C57BL/6 mice homozygous for the deficient cftr gene and the CFTR-normal bone
marrow-derived macrophages were produced from C57BL/6 mice homozygous for wild
type cftr gene (84). Both cell lines were kindly provided by Dr. D. Radzioch, McGill
University, Montreal, Canada. Confirmation of the integration of the gene-targeting
construct within cftr gene of CFTR-defective macrophages was performed by PCR (see
section 2.4). ANA-1 macrophages are a bone-derived macrophage cell line from CFTR-
normal C57BL/6 mice kindly provided by the Department of Human Genetics, Montreal
General Hospital Research Institute, McGuill University, Montreal, Canada.
Macrophages were maintained in Dulbecco’s modified Eagle medium (DMEM) with 10%
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fetal bovine serum (FBS) and grown at 37°C in a humidified atmosphere of 95% and 5%
carbon dioxide.
2.3 Reagents
DMEM, phosphate buffered saline (PBS), and (FBS) were purchased from Wisent Inc.
RPMI-1640 medium was purchased from Sigma-Aldrich ®. 6-
Carboxytetramethylrhodamine hydroxysuccinimide ester (TAMRA) was purchased from
Molecular Probes, Inc. 6-Methoxyquinoline, N-hydroxysuccinimide, 1-(3-
Dimethylaminopropyl)-3-ethylcarbodiimide, and 6-Bromohexanoic acid were purchased
from Sigma-Aldrich ®. Standard Rabbit Complement (Pooled Normal Rabbit Serum)
composed of active complement components was purchased from Cedarlane®.
Myeloperoxidase Chlorination Assay Kit was purchased from Cayman Chemical
Company. CytoTox 96® Non-Radioactive Cytotoxicity Assay was purchased from
Promega. Cl--solution and Cl--free gluconate solution were made to maintain osmotic
balance in assays. The Cl-- solution consisted of 122 mM NaCl, 1.2 mM magnesium
gluconate, 4 mM calcium gluconate, 2.4 mM K2PO4, 0.6 mM KH2PO4, 10 mM dextrose,
20 mM Hepes (pH 8.2). The Cl--free gluconate solution consisted of the same
concentrations of all the chemical reagents of the Cl--solution with the exception of 122
mM NaCl, which was substituted for 122 mM sodium gluconate. Sodium gluconate is a
non-quenching ion of the TAMRA and MQHA fluorophores.
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2.4 Confirmation of plasmid integration within the cftr gene
A 400-bp internal fragment of the murine exon 10 corresponding to the plasmid insertion
site in CFTR-defective macrophages (50) was amplified from CFTR-normal macrophage
genomic DNA using the primers CFEx10NT (5’-GGAATTATTAAGCACAGTGGAAGAG-
3’) and CFEx10CT (5’-GCTTTACTGGAGAAAGTAAGCTACTAG-3’) (Figure11). 600-bp
fragments corresponding to β-actin were amplified from CFTR-normal and CFTR-
defective macrophage genomic DNA. DNA denaturation occurred for 45 sec at 95°C.
Primers were allowed to anneal for 45 sec at 62°C and extension was for 1min at 72°C.
The cycle was repeated 30 times. Macrophage genomic DNA was purified using Qiagen
DNeasy Tissue Kit.
2.5 Cl- sensor (MQHA) synthesis
The Cl- sensitive probe was synthesized by covalently binding the fluorescent sensitive
fluorophore 6-methoxyquinoline to a carboxylic acid 6-bromohexanoic acid generating 6-
Methoxyquinoline-N-6-hexanoic acid (MQHA). 1:1.5 molar ratio of 6-methoxyquinoline
(879 µl) and 6-bromohexanoic acid (1.84 g) were heated in a total volume of 879 µl to
110°C for 4 hrs in a closed glass vial without the addition of a solvent. The product was
stirred in acetone overnight to separate bromide from the product. This suspension was
centrifuged at 27, 216 x g for 4 mins. During the following hot filtration step: soluble
impurities and the desired product are solubilised in the smallest amount of solvent
required to dissolve the mixture; and the mixture is subsequently cooled to room
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temperature allowing the solubility of the product to drop resulting in the crystallization of
the product from the solvent containing solubilised impurities. Ethanol was heated to a
boil and added drop-wise to the product (the pellet) until the opaque, beige product
turned into a clear, yellow liquid. The liquid was poured into a stem-less glass funnel
with fluted filter paper and filtered via gravity to remove insoluble impurities including
dust. The purpose of using a glass funnel without a stem was to avoid product loss due
to the possibility of the product crystallizing in the stem during gravity filtration. The
fluted paper allowed for free air circulation in the receiving flask, which equalized the
pressure preventing a decrease in filtration speed. The flask was left undisturbed
overnight at room temperature for the product to crystallize from the solvent containing
solubilised impurities. The crystals and remaining fluid with solubilised impurities were
poured into a Buchner funnel with filter paper and a vacuum was applied. A few drops of
ethanol were added to wash the crystals during filtration. Once the crystals dried from
vacuum filtration, they were placed in an opaque bottle and kept in the dark.
2.6 Cl- detection assay
B. cenocepacia MH1K were opsonised with rabbit serum while rotating at room
temperature for 1hr. MH1K were spun for 1 min at 16.1 x g and the supernatant was
discarded. MH1K were labeled with 5mg MQHA in the presence of 5mg N-
hydroxysuccinimide, and 5mg carbodiimide in 100 µl Tris-maleate buffer at pH 8.2.
MH1K were spun for 1 min at 16.1 x g and the supernatant was discarded. The MH1K
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pellet was labeled with 20ul of 25 mg/ml TAMRA. MH1K were washed by centrifugation
at 16.1 x g with Cl--free gluconate solution until supernatant was clear. A calibration
curve was formed by exposing MQHA and TAMRA labelled B. cenocepacia to NaCl.
CFTR-normal and CFTR-defective macrophages were washed with the Cl--free
gluconate solution. Macrophages were seeded in 96 well sterile tissue culture treated
white plates with lids (Nunc cat# 136102 – F96 Nunclon Delta white sterile).
Macrophages were infected with MQHA and TAMRA labelled B. cenocepacia at a
multiplicity of infection (m.o.i) of 30 (3x107 B. cenocepacia per 1x106 macrophages in a
well equal to 30 B. cenocepacia for each macrophage) and incubated for 1 hr.
Macrophages were washed with Cl--free gluconate solution and incubated for ½ hr in Cl-
-free gluconate solution with 50 μg/ml gentamicin. Macrophages were washed with Cl--
free gluconate solution and incubated for 1, 4, and 6-hrs in either a Cl--free gluconate
solution or in a Cl--solution with 10μg/ml gentamicin. Following the indicated times, the 
fluorescence signal of MQHA was measured at excitation and emission wavelengths of
350 and 450 nm respectively and of TAMRA was measured at excitation and emission
wavelengths of 540 and 565 nm respectfully.
2.7 Exposure of macrophages to Cl--solution upon bacterial infection controlled
with the gentamicin protection assay
CFTR-normal, CFTR-defective and ANA-1 macrophages were washed with Cl--free
gluconate solution. Macrophages were infected with B. cenocepacia (see section 2.6,
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omit labelling of B. cenocepacia). Following 1 and 6-hrs post-exposure to Cl--solution/Cl-
- free gluconate solution, macrophages were washed with Cl--free gluconate and
macrophages were lysed in 1 ml of 0.1% Triton X-100 detergent. 100 μl aliquots were 
serially diluted and plated on LB agar plates in duplicate. Plates were incubated
overnight at 37°C and colony forming units (CFUs) were quantified. A lactate
dehydrogenase (LDH) release assay was used to control for cytotoxicity of
macrophages. B. cenocepacia survival was plotted as CFUs/ml obtained at 6 hrs post-
exposure to Cl--solution/Cl-- free gluconate solution over CFUs/ml obtained at 1 hr post-
exposure to Cl--solution/Cl--free gluconate solution.
2.8 Hypochlorous acid sensitivity assay
B. cenocepacia MH1K, E. coli DH5α, and B. multivorans C5568 were washed with PBS.
Bacteria (5x108) were exposed to 0.5, 0.2, 0.1, 0.06 and 0.03 mM HOCl in a total
volume of 1ml PBS for 1 hr at 37°C while shaking. 100 μl were serially diluted and plated 
on LB agar plates in duplicate. LB plates were incubated at 37°C overnight and CFUs
were quantified.
2.9 Myeloperoxidase activity detection assay
A colorimetric assay was used to detect MPO chlorination activity. The non-fluorescent
2-[6-(4-aminophenoxy)-3-oxo-3H-xanthen-9-yl]-benozoic acid (APF) is selectively
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cleaved by hypochlorite to yield the fluorescent compound fluorescein (82). Fluorescein
standard at a concentration of 1μM was serially diluted (1 in 200) in glass tubes with 
PBS (pH 7.4) and 60 μl aliquots of the each dilution were transferred to 8 wells 
containing 50 μl PBS. Measurements were taken with a fluorometer at emission and 
excitation wavelengths of 480 and 515 nm respectively to establish the appropriate
GAIN for detecting the entire range of standards. Cell lysates were obtained following
the instructions in the kit’s protocol, which instructed to sonicate 7x106 CFTR-normal,
CFTR-defective macrophages and THP1 monocytes in PBS on ice. A working solution
containing 2.44ml PBS, 40 μl of chlorination substrate at a concentration of 2.5 mM, and 
20 μl of H2O2 at a concentration of 5mM was prepared. Aliquots of 50 μl of each 
supernatant were transferred to 6 wells containing 10ul PBS. Aliquots of 10 μl of MPO-
chlorination inhibitor 4-aminobenzhydrazide at a concentration of 1mM were added to 3
of the 6 wells. Aliquots of 50 μl MPO at a concentration of 250 ng were added to three 
additional wells containing only 10 μl PBS. Aliquots of 50 μl of the working solution were 
added to all of the wells. Measurements with the fluorometer were taken every 5 min for
1 hr at excitation and emission wavelengths of 480 and 515 nm respectively.
2.10 Statistical Analysis
One-way analysis of variance (ANOVA) with post-hoc Tukey-Kramer tests was
performed with Graphpad Prism® software (GraphPad Prism version 4.00 for Windows,
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GraphPad Software, San Diego California USA) to analyze the statistical significance of
differences among groups. Probability values of P < 0.05 were considered significant.
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3 Results
3.1 Cl- sensor synthesis
The Cl--sensitive fluorophore MQHA was synthesized resulting in the Cl--sensitive 6-
methoxyquinoline molecule with one or more conjugated carboxyl acyl chains. The
function of the carboxyl group at the end of the acyl chain is to bind to amines on the
surface of B. cenocepacia. Carbodiimide was added to this reaction to activate the
carboxyl groups toward forming amide bonds with the amines on the surface of B.
cenocepacia. Hydroxysuccinimide was also added to this reaction to prevent side
reactions and increase the number of amide bonds. The formation of the expected
MQHA product with a molecular mass of 274 g/mol was confirmed by mass
spectrometry (Figure 6B). Forms of MQHA with additional carboxylic chains were also
detected (Figure 6C, D and E). The mother compound 6-methoxyquinoline was also
detected (Figure 6A).
The MQHA product was exposed to different Cl- concentrations to assess the level of
MQHA sensitivity to Cl- within a physiological range. Two additional molecular forms of
Cl- (HOCl, and KCl) that are expected in the phagosomal environment were assayed
also against MQHA (Figure 7). The Ksv values for MQHA exposed to each of NaCl,
HOCl, and KCl were determined to for calculating the half maximal effective
concentration (EC50). The EC50 defines the Cl- concentration required to elicit a 50%
decrease in fluorescence intensity, in turn indicating the strength of the quencher. The
42
EC50 was derived from the Stern-Volmer equation F0/F = 1 + Ksv[Cl-] to be 1/Ksv. The Ksv
and EC50 for NaCl quenching MQHA were 54 M-1 and 19 mM respectively. Ksv 55 M-
1and EC50 18 mM corresponded to MQHA quenching by KCl. The Ksv and EC50 for
MQHA quenching by HOCl were 10 M-1 and 101 mM respectively. According to these
calculations HOCl is a 5-fold weaker quencher of MQHA than KCl and NaCl. MQHA was
also exposed to 500 mM NaCl to verify that the relationship of MQHA quenching by Cl-
remains linear beyond the physiological range of Cl- (Figure8).
3.2 Confirmation of CFTR-normal and CFTR-defective macrophage lines
The lack of the corresponding 400-bp fragment amplicon from CFTR-defective
macrophages confirms the absence of cftr gene expression due to the successful
targeted interruption of exon 10 of the CFTR gene distinguishing these macrophages as
CFTR-defective macrophages (Figure 9). A 600-bp fragment corresponding to β-actin 
was amplified from CFTR-normal and CFTR-defective genomic DNAs as PCR controls
(Figure 9).
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Figure 6. Mass spectrum of MQHA. MQHA purity was determined by mass
spectrometry. 9.876 mg of MQHA were submitted for mass spectrometry. Mass
spectrometry was performed on a QTOF-Micro mass spectrometer equipped with a Z-
spray source and run in positive ion mode.
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Figure 7. Plot of the quenching of MQHA fluorescence by HOCl, NaCl, and KCl
salts at concentrations comparable to those present in the phagosome at
concentrations comparable to those present in the phagosome. Aliquots of 100 μl 
HOCl, NaCl, and KCl each at a concentration of 122 mM were serially diluted in a
microtitre plate. Aliquots of 2 μl of MQHA at a concentration of 2 mg/ml were added to 
each well. The MQHA fluorescence signal was measured with a fluorometer at
excitation and emission wavelengths of 350 and 450 nm respectively. Data are plotted
as the ratio of MQHA signal in deionised water to MQHA signal in a salt solution as a
function of Cl- concentration according to the Stern-Volmer equation F0/F = 1 + Ksv [Cl-],
which defines the quenching of MQHA fluorescence.
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Figure 8. Plot of the quenching of MQHA fluorescence by a range of NaCl
concentrations. Aliquots of 100 μl NaCl at a concentration of 122mM were serially 
diluted in a microtitre plate. Aliquots of 2 mg/ml MQHA were applied to each well. The
MQHA fluorescent signal was measured with a fluorometer at excitation and emission
wavelengths of 350 and 450 nm. Data are plotted as the ratio of MQHA in deionised
water to MQHA exposed to NaCl as a function of Cl- concentration.
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Figure 9. Agarose gel displaying PCR products from CFTR-normal and CFTR-
defective macrophages. Genomic DNA isolated from CFTR-normal and CFTR-
defective macrophages was subjected to PCR. A 400-bp fragment was amplified from
CFTR-normal macrophage DNA representing CFTR expression (lane 4). The 400-bp
amplicon is absent from CFTR-defective macrophage DNA (lane 2). Fragments
consisting of 600-bps were amplified representing the β-actin loading control for CFTR-
defective and CFTR-normal and macrophages (lanes 3 and 5).
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3.3 Intraphagosomal Cl- measurements in CFTR-normal and CFTR-defective
macrophages
The CFTR-defective macrophages lack cftr gene expression, which may result in lower
intraphagosomal Cl- concentration in these macrophages compared to CFTR-normal
macrophages. The intraphagosomal Cl- concentration was investigated to determine
whether or not intraphagosomal Cl- concentration of phagosomes containing B.
cenocepacia differs between CFTR-normal and CFTR-defective macrophages. B.
cenocepacia were covalently labeled with Cl--sensitive MQHA (see section 2.6). MQHA
labelled B. cenocepacia were subsequently covalently labelled with Cl--insensitive
fluorophore TAMRA providing a reference for ratiometric analysis (see section 2.6). B.
cenocepacia labelled at a ratio of 1 to 5 of MQHA to TAMRA respectively were exposed
to different levels of NaCl and a fluorometer was used to measure the signals of the
TAMRA and MQHA fluorophores. A calibration curve showing the ratio of TAMRA signal
to MQHA signal as a function of increasing NaCl concentration was generated (Figure
10A). To compare intraphagosomal Cl- concentrations of phagosomes containing B.
cenocepacia, CFTR-normal and CFTR-defective macrophages were infected with
MQHA- and TAMRA-labeled B. cenocepacia and incubated in either Cl--solution or Cl--
free gluconate solution (see section 2.6). To eliminate the effects of extracellular
bacteria, these experiments were performed with the gentamicin-sensitive strain of B.
cenocepacia called MH1K which was recently constructed in our laboratory by
markerless deletion of the genes forming the operon encoding the AmrAB-OprA-like
efflux pump, which mediates resistance to aminoglycosides including gentamicin (32).
Gentamicin kills extracellular bacteria without affecting bacterial viability and trafficking
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of intracellular bacteria (32). Following 1 hr infection with labeled B. cenocepacia, 50
µg/ml gentamicin were added to kill extracellular B. cenocepacia bacteria and
synchronize the infection. Macrophages were washed with PBS to remove killed
extracellular B. cenocepacia and further cultured in their respective solutions with 10
µg/ml gentamicin. Gentamicin kills B. cenocepacia MH1K at a concentration of 10 µg/ml,
however a higher concentration of 50 µg/ml gentamicin were used at the beginning of
the experiments to ensure rapid extracellular killing of B. cenocepacia (32). At the
indicated times a fluorometer was used to measure fluorescence signals of TAMRA and
MQHA emitted from the labeled B. cenocepacia in the CFTR-normal and CFTR-
defective macrophages incubated in either the Cl--solution or Cl--free gluconate solution
to obtain the ratio of TAMRA to MQHA (see section 2.6). This ratio was compared to the
calibration curves generated for each new experiment to determine the intraphagosomal
Cl- concentration. Following the last measurement, the Cl--solution or Cl--free gluconate
solutions bathing the macrophages were transferred to clean wells and the background
fluorescence was measured. These experiments showed no significant differences in
the intraphagosomal Cl- concentrations of B. cenocepacia infected CFTR-normal and
CFTR-defective macrophages despite expression of the cftr gene encoding the CFTR
Cl- channel in CFTR-normal macrophages and a lack of cftr gene expression in the
CFTR-defective macrophages (Figure 10B, C and D).
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Figure 10. Intraphagosomal Cl- concentration in CFTR-normal and CFTR-defective
macrophages. A Representation of a calibration curve showing the ratio of TAMRA to
MQHA signals plotted as a function of Cl- of MQHA and TAMRA labeled B. cenocepacia
exposed to increasing concentrations of NaCl (A). Macrophages were incubated for 1 hr
(B), 4 hrs (C), and 6 hrs (D) with MQHA and TAMRA labelled B. cenocepacia at an m.o.i
of 30 and exposed to either a Cl--solution or Cl--free gluconate solution. Following each
incubation time point, MQHA signals were measured at excitation and emission
wavelengths of 350 and 450 nm respectively and TAMRA signals were measured at
excitation and emission wavelengths of 540 and 565 nm respectively. The
intraphagosomal Cl concentration was determined from the ratio of TAMRA to MQHA
using the calibration curve. The values represent the mean and standard deviation of
three experiments in quadruplicate. Comparison of these groups for statistical difference
was performed using one-way ANOVA with post-hoc Tukey-Kramer tests (P< 0.05).
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3.4 B. cenocepacia survival in CFTR-defective macrophages
The MPO-dependent HOCl generating reaction requires H2O2 and Cl-. NADPH oxidase
assembly on the phagosomal membrane of BcCVs accompanied by the O2.- generating
oxidative burst was shown to be delayed by 6 and 8-hrs in B. cenocepacia infected
CFTR-normal and CFTR-defective macrophages (47). CFTR-normal and CFTR-
defective macrophages appear to have similar levels of Cl- in their phagosomes
containing B. cenocepacia (Figure 10B, C and D). However the temporal delay in the
generation of the O2.- precursor for H2O2 may delay the generation of HOCl interfering
with the efficient clearance of B. cenocepacia. Therefore, we determined the survival of
B. cenocepacia in CFTR-normal and CFTR-defective macrophages using the MH1K
strain (see section 3.3). To examine bacterial survival relative to Cl- concentration,
CFTR-normal and CFTR-defective macrophages were incubated in either Cl--solution or
Cl--free gluconate solution. At the indicated times, macrophages were lysed and viable
bacteria quantified via serial dilutions and colony counts. The data reveal no significant
difference in the survival of B. cenocepacia in CFTR-normal and CFTR-defective
macrophages at 6 hrs post-exposure to Cl--solution/Cl--free gluconate solution (Figure
11A). In parallel, an LDH release assay was used to control for cytotoxicity at each of
the incubation time points using the CytoTox 96® Non-Radioactive Cytotoxicity Assay.
Lactate dehydrogenase (LDH) is a soluble cytosolic enzyme that is released into the
culture medium following loss of membrane integrity resulting from either apoptosis or
necrosis. At each indicated time, aliquots of Cl--solution or Cl--free gluconate solution
from wells holding infected and uninfected macrophages and uninfected macrophages
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exposed to sodium dodecyl sulfate (SDS) were transferred to a 96 well plate. Following
application of substrate mix to each of the wells and a spectrophotometer was used to
measure absorbance at 480 nm. Percent toxicity was determined by substituting the
measured values into the following equation: cytotoxicity (%) = (Infected macrophage
aliquot - uninfected macrophage aliquot)/ (SDS aliquot - uninfected macrophage
aliquot). According to the LDH assay assessing cytotoxicity, macrophage death at 6 hrs
of incubation ranges from 20-40% (Figure 11B) suggesting that macrophages may be
dying due to deprivation of essential nutrients found in their culture media and that
measurements concerning: intraphagosomal Cl- in CFTR-normal and CFTR-defective
macrophages; and B. cenocepacia survival in CFTR-normal and CFTR-defective
macrophages taken beyond 6 hrs of incubation may not be accurate.
B. cenocepacia survival was also measured in Ana-1 macrophages to confirm that the
results obtained for B. cenocepacia survival in CFTR-normal and CFTR-defective
macrophages are not specific to only these two cell types. Again, no significant
differences in B. cenocepacia survival were observed at 6 hrs post-exposure to Cl--
solution/Cl--free gluconate solution in ANA-1 macrophages (Figure 12A).
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Figure 11. B. cenocepacia survival in CFTR-normal and CFTR-defective
macrophages. (A) CFTR-normal and CFTR-defective macrophages were infected with
B. cenocepacia at an m.o.i of 30 and incubated for 1hr Cl--free gluconate solution,
followed by ½ hr incubation in Cl--free gluconate solution with 50 μg/ml gentamicin. 
Macrophages were further incubated for 1 or 6-hrs in either a Cl--solution or Cl--free
gluconate solution with 10 μg/ml gentamicin. Macrophages were lysed in 1 ml of 0.1% 
Triton X-100 detergent. 100 μl aliquots were serially diluted and plated on LB agar plates 
incubated overnight at 37°C. Colony forming units (CFUs) were quantified. Data were
normalized relative to values obtained at 1 hr post -exposure to Cl--solution/Cl--free
gluconate solution. (B) Cytotoxicity of macrophages was determined by comparing the
measured amount of LDH in the solutions bathing the macrophages to the measured
amount of total LDH in macrophages released upon macrophage lysis with SDS.
Substrate mix was added to aliquots taken from wells holding: infected and uninfected
macrophages; and uninfected macrophages exposed to sodium dodecyl sulfate (SDS).
Following application of substrate mix to each of the wells absorbance was measured at
480 nm. The values represent the average and standard deviation of 3 experiments in
duplicate. Comparison of these groups for statistical difference was performed using
one-way ANOVA (P< 0.05).
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Figure 12. B. cenocepacia survival in Ana-1 murine macrophages. Ana-1
macrophages were infected with B. cenocepacia at an m.o.i of 30 and incubated for 1hr
Cl--free gluconate solution, followed by ½ hr incubation in Cl--free gluconate solution
with 50 μg/ml gentamicin. Macrophages were further incubated for 1 or 6-hrs in either a 
Cl--solution or a Cl--free gluconate solution with 10 μg/ml gentamicin. Macrophages were 
lysed in 1 ml of 0.1% Triton X-100 detergent. 100 μl aliquots were serially diluted and 
plated on LB agar plates incubated overnight at 37°C. Colony forming units (CFUs) were
quantified. Data were normalized relative to values obtained at 1 hr post -exposure to Cl-
-solution/Cl--free gluconate solution. (B) Cytotoxicity of macrophages was determined by
comparing the measured amount of LDH in the solutions bathing the macrophages to
the measured amount of total LDH in macrophages released upon macrophage lysis
with SDS. Substrate mix was added to aliquots taken from wells holding: infected and
uninfected macrophages; and uninfected macrophages exposed to sodium dodecyl
sulfate (SDS). Following application of substrate mix to each of the wells absorbance
was measured at 480 nm. The values represent the average and standard deviation of 3
experiments in duplicate. Comparison of these groups for statistical difference was
performed using one-way ANOVA with post-hoc Tukey-Kramer tests (P< 0.05).
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3.5 Chlorination detection assay
It is essential to determine the presence and/or level of MPO and MPO enzyme activity
in the CFTR-normal and CFTR-defective macrophages, despite no significant difference
being found in the intraphagosomal Cl- concentrations of phagosomes containing B.
cenocepacia between CFTR-normal and CFTR-defective macrophages (Figure 10B, C
and D). The level of MPO-like enzyme activity was investigated in cell lysates from
CFTR-normal and CFTR-defective macrophages and THP-1 monocytes with the
Myeloperoxidase Chlorination Assay Kit as described in Materials and Methods (see
section 2.9). A working solution containing all the reagents necessary for a MPO-like
reaction, including PBS containing NaCl and H2O2 was added to macrophage and
monocyte lysates. The working solution also contained a chlorination substrate APF that
is cleaved only in the presence of a MPO-like enzyme generating HOCl. The
chlorination substrate APF only emits a fluorescent signal upon being cleaved by HOCl.
The signal detected from the lysates of macrophages and monocytes exposed to the
working solution was compared to the signal obtained from the lysates of macrophages
and monocytes exposed to the working solution containing an inhibitor of MPO. MPO-
like chlorination activity was not detected in the lysates of CFTR-normal and CFTR-
defective macrophages (Figure 13A and B). MPO-like chlorination activity was also
absent from the lysates of THP-1 monocytes (Figure 13C). Exogenous MPO added to
wells containing only the working solution resulted in the detection of a fluorescent
signal that increased over time indicating that the chlorination substrate APF was being
cleaved by the HOCl generated by the system, indicating that the system works (Figure
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13D). In turn, this result confirms that MPO-like chlorination activity is absent from the
CFTR-normal and CFTR-defective macrophages, as well as from the THP-1 monocytes.
3.6 B. cenocepacia sensitivity to hypochlorous acid
Data from our laboratory visualizing phagolysosomal fusion with the LAMP-1 marker
indicate that after B. cenocepacia ingestion, CFTR-defective macrophages exhibit a
pronounced delay in phagolysosomal fusion in comparison to CFTR-normal
macrophages (53) suggesting CFTR may contribute to the clearance of intracellular B.
cenocepacia. In CFTR-defective neutrophils there is a defect in the chlorination of
tyrosine residues on bacterial proteins by HOCl preventing clearance of P. aeruginosa
infection (68). We then investigated the degree of sensitivity of B. cenocepacia to HOCl
in comparison to lab stocks of non-Bcc strain E. coli DH5α and Bcc strain B. multivorans
C5568. Bacteria grown to late stationary phase were exposed to different concentrations
of HOCl for 1 hr and CFUs were enumerated from plated serial dilutions. The results
show that the three strains are sensitive to low concentrations of HOCl (Figure 14).
There is also no significant difference in sensitivity to HOCl between the three strains
suggesting that B. cenocepacia would not exhibit a survival advantage over E. coli and
the CF pathogen B. multivorans in a vacuole containing HOCl (Figure 14).
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Figure 13. Absence of MPO chlorination activity in macrophages and monocytes.
For CFTR- normal (A), CFTR-defective (B) THPI (C) cell lysates, and positive control (D)
measurements with the fluorometer are taken every 5 mins for 1 hr at excitation and
emission wavelengths of 480 and 515 nm respectively. The values represent the
average and standard deviation of 2 experiments in triplicate. Comparison of these
groups for statistical difference was performed using one-way ANOVA with post-hoc
Tukey-Kramer tests (P< 0.05).
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Figure 14. Intrinsic sensitivity of B. cenocepacia to HOCl. B. cenocepacia MH1K, E.
coli DH5α, and B. multivorans C5568 grown to late stationary phase in LB broth were
exposed to HOCl at concentrations of 0.5, 0.2, 0.1, 0.06 and 0.03 mM for 1hr. The
values represent the average and standard deviation of 2 experiments in duplicate.
Comparison of these groups for statistical difference was performed using one-way
ANOVA with post-hoc test Tukey (P< 0.05).
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Chapter 4
4 Discussion and conclusions
4.1 The role of CFTR in the clearance of B. cenocepacia
The lack of a significant difference in the concentrations of Cl- between phagosomes of
CFTR-normal and CFTR-defective macrophages containing B. cenocepacia (Figure
10B, C and D) suggests that Cl- transport by CFTR does not play a significant role in
arming the phagosome with essential Cl- ions presumably required for microbicidal
activity. Recently, the cooperation of 2 bacterial secretory systems TVISS and type two
secretion system (TIISS) was found to be critical for the damage of the BcCV membrane
and escape of bacterial proteins into the cytosol that in turn activate the NLRP3
inflammasome (Rosales-Reyes, R.; in press). NLRP3 belongs to the cytoplasmic
nucleotide oligomerization domain receptor family that activates caspase-1 by forming
multiprotein complexes called inflammasomes (40). The adaptor molecule ASC is
recruited by activated NLRP binding inactive procaspase-1 and an active caspase-1
results from autocatalytic processing that in turn catalyzes cleavage of procytokine IL-1β 
(2, 40).The active IL-1β  cytokine promotes inflammatory responses and leukocyte 
infiltration (2). It is possible that the Cl- in the vacuole may be leaking out of the
damaged BcCV resulting in the lack of difference between Cl- concentrations of CFTR-
defective and CFTR-normal macrophages infected with B. cenocepacia.
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Alternatively, the escape of cations through the damaged vacuole may significantly
affect the role of CFTR in the clearance of bacteria by macrophages. Macroautophagy is
dependent on the regulation of inositol 1, 4, 5-triphosphate (IP3) (100). Intracytosolic
Ca+ in eukaryotic cells regulates cAMP levels which in turn regulate IP3 (100). For
example, low levels of Ca+ result in low levels of cAMP that decrease levels of IP3
resulting in the induction of autophagy. TVISS mediated BcCV membrane disruption
may lead to spillage of Ca+ into the cytosol and result in the following outcome. In
CFTR-normal macrophages B. cenocepacia have been shown to reside in
autophagosomes that fuse with lysosomes (2). The increase in cytosolic Ca+ may lead
to an increase in cAMP required for PKA mediated phosphorylation of the CFTR
regulator domain and subsequent activation of CFTR to drive transport of Cl- into the
phagosome. There is also an assumed basal level of cytosolic cAMP that is available to
CFTR. The functional CFTR would use the basal level of cAMP and the decrease is
available cAMP would lead to autophagy. However, the extra cAMP resulting from the
spillage of Ca+ may prevent complete autophagy in an infected macrophage in contrast
to an uninfected macrophage. In CFTR-defective macrophages B. cenocepacia have
been shown not to reside in autophagosomes (2). The increase in cytosolic Ca+
resulting from the damaged BcCV may lead to an increase in cAMP, but CFTR has a
functional defect that may be preventing cAMP-mediated PKA activation of CFTR. There
is also an assumed basal level of cytosolic cAMP that is available to CFTR. The result
may be that there could be a sufficient accumulation of cytosolic cAMP to prevent
autophagy. The level of cAMP can be measured in B. cenocepacia infected and not
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infected CFTR-normal and CFTR-defective macrophages with a competition enzyme-
linked immunoassay where cAMP competes with horse radish peroxidase-linked cAMP
for binding to Rabbit monoclonal antibody immobilized to the surface of a plate. An
important control for this experiment is the TVISS B. cenocepacia mutant that does not
compromise the BcCV membrane resulting in similar levels of cAMP in CFTR-normal
macrophages as expected in uninfected CFTR-normal macrophages. Survival of B.
cenocepacia in CFTR-normal and CFTR-defective macrophages to the same degree
(Figure 11A) indicates that CFTR mediated Cl- transport does not play a role in the
clearance of B. cenocepacia infection. The role of CFTR in the clearance of B.
cenocepacia may be independent of phagosomal ion concentrations and instead affect
autophagy.
The absence of MPO activity from CFTR-normal and CFTR-defective macrophages
(Figure 13A and B) reveals that if Cl- is transported into the phagosome via CFTR, it is
not required for a MPO-like mediated oxidative destruction of internalized B.
cenocepacia. B. multivorans and E. coli are equally sensitive as B. cenocepacia to HOCl
(Figure 14). These data suggest that neutrophils and macrophages eliminate pathogens
via different oxidative mechanisms. Recent work indicates that bacterial clearance, once
thought to occur strictly through MPO-mediated oxidative mechanisms in neutrophils,
occurs through both oxidative activity and protease action (6). Reeves et al show that
the influx of K+ to offset the negative charge from the electrons that pass through the
NADPH oxidase results in a hypertonic environment in the vacuole that releases cationic
proteases cathepsin G and elastase from the anionic sulfated proteoglycan matrix to
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directly interact and destroy pathogens (6). K+ pumps are regulated by CFTR (30).
Control of hypertonicity is regulated by GTPases Rac and Cdc42that modulate the
cytoskeleton (7, 72). B. cenocepacia inactivate Rac and Cdc42 disrupting the actin
cytoskeleton in macrophages (23). The disruption in hypertonicity regulation in CFTR-
normal macrophages by B. cenocepacia may be responsible for the delay in BcCV
trafficking to the lysosome. In CFTR-defective macrophages the disruption in
hypertonicity in concert with the lack of K+ pump regulation may lead to the further
prolonged maturation arrest of BcCVs. With respect to the data generated by Reeves et
al, ROS generated by the oxidative burst and the release of proteases may be
necessary and sufficient to clear bacterial infections without the MPO-mediated HOCl
pathway.
A short coming of this work concerns the Cl--solution and Cl--free gluconate solution
used for the assays measuring Cl- concentration (Figure 10 B, C and D) and B.
cenocepacia survival in CFTR-normal and CFTR-defective macrophages (Figure 11A
and B). The Cl--solutions and Cl--free gluconate solutions and are commonly used as
buffers for assays measuring ion concentrations. However, the sufficient data for these
experiments were collected within 1 hr of exposing the cells to the gluconate solution
limiting these assays to 1 hr (45, 62, 65). The desired measurements for this work are
obtained at 6 hrs post-exposure to Cl--solution/Cl--free gluconate solution due to interest
in obtaining the intraphagosomal Cl- concentration at the moment that B. cenocepacia
are manipulating phagosomal maturation. The DMEM media that the CFTR-normal and
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CFTR-defective macrophages are cultured in is not available in a Cl--free form limiting
the assays to be conducted in the Cl--free gluconate solution and the comparable Cl-
containing gluconate solution (see section 2.3) that may be responsible for high
cytotoxicity beyond 6 hrs post-exposure to Cl--solution/Cl--free gluconate solution. A
possible solution is to add a chelator of Cl- to the DMEM media to simulate the Cl--free
condition allowing the macrophages to remain in the specific media that they require for
growth without the stress associated with a foreign media that could alter intracellular
trafficking.
4.2 Future experiments
In addition to undergoing endocytic recycling, CFTR undergoes regulated trafficking
between intracellular compartments and the cell surface (3).The source of CFTR on the
BcCV membrane is not known. CFTR on the BcCV membrane may originate from the
plasma membrane due to endocytic recycling or during B. cenocepacia uptake and
follow the maturation of the BcCV under the regulation of Rab GTPases. Another
possibility is that CFTR may originate on the BcCV membrane due to regulated
trafficking between intracellular compartments or directly from the TGN. Rab GTPases
mediate the intracellular trafficking of CFTR (3). B. cenocepacia infection affects Rab7
(42). Perhaps B. cenocepacia promote their survival by manipulating Rab GTPases to
diminish the amount of CFTR at the surface of the cell and maturing phagosomes.
CFTR localized to the membrane of phagosomes may regulate cellular processes that
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are required for the efficient clearance of B. cenocepacia The crucial experiment is to
characterize the subcellular distribution of CFTR during B. cenocepacia infection at
various time points to decipher B. cenocepacia’s influence on CFTR trafficking during
infection. Immunoelectron microscopic localization with high affinity specific antibodies
or cryoimmunoelectron microscopy are methods that have proven to be successful in
characterizing subcellular distribution of CFTR in rat submandibular glands and rat
intestinal tissue (3).
The experiments measuring intraphagosomal Cl- concentration in the 2 cell types should
be repeated using a TVISS B. cenocepacia mutant labelled with TAMRA and MQHA. In
addition, intraphagosomal Cl- concentration can be measured with labelled bacterial
species lacking the TVISS. The lack of the TVISS may prevent the rupture of BcCVs
and the resulting leakage of Cl- out of the vacuole allowing for an accurate measurement
of Cl- concentration in BcCVs. Furthermore, Cl- concentration can be measured in single
cells to determine Cl- concentration per cell using a Flow Cytometer with a laser that
excites at 350 nm.
4.3 Significance and concluding remarks
B. cenocepacia are found ubiquitously in the environment and this characteristic
adaptation to several niches is thought to be responsible for their survival and
persistence within host cells. Previous work shows that uninfected CFTR-defective
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murine macrophages display normal acidification and that the observed CFTR-
associated phagosomal maturation defect in CFTR- defective murine macrophages
infected with B. cenocepacia suggests that CFTR plays a role in the persistence of B.
cenocepacia infection (54). The work concerning this thesis does not support the
hypothesis that macrophages with dysfunctional CFTR lack sufficient Cl- concentrations
for the chlorination of phagocytosed B. cenocepacia cells and the subsequent clearance
of infection. However, CFTR may still play an indirect role in clearance of B.
cenocepacia, which is likely independent of oxidative killing and phagosomal
acidification via an alternative pathway. The significance of this work is the
demonstration that B. cenocepacia clearance by murine macrophages occurs through a
chlorination independent system implying that clearance of bacterial infection by
neutrophils and macrophages occurs through distinct mechanisms. The relationship
between the CFTR defect and B. cenocepacia intracellular persistence in murine
macrophages remains to be elucidated.
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